OncoSec to Host Fourth Quarter and Fiscal Year End Financial Results Conference Call on October 13, 2016 Sep 30, 2016
OncoSec Announces Peer-Reviewed Publication of T-Cell Exhaustion Marker to Predict Response to Anti-PD-1 Therapy in Melanoma Aug 15, 2016
OncoSec Presents Significant Advancements in Electroporation Technology for Immunotherapy Jun 28, 2016
OncoSec Presents Preliminary Findings from Head and Neck Phase II Clinical Trial at EUROGIN 2016 Conference Jun 16, 2016
OncoSec Collaborators Present Results of Novel T-Cell Exhaustion Marker to Predict Response to Anti-PD-1 Monotherapy Jun 6, 2016
